Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The study is a prospective, double-blinded, placebo-controlled multi-center trial to measure
if postoperative pain and the amount of narcotics used are reduced by a clinically
significant amount in women undergoing minimally invasive hysterectomy receiving a continuous
infusion of intraperitoneal (IP) local anesthetic (LA) or a continuous infusion of LA
combined with an NSAID compared with a control group who receives only 0.9% normal saline.